The Regimen of Cladribine, Cytarabine, and Venetoclax (CAV) Induces Apoptosis in Acute Myeloid Leukemia Cells by Enhancing DNA Damage
Journal of Visualized Experiments · 2026
DOI: 10.3791/69797 ↗Kurz gefasst
Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2026. Verfasst von Fang-Tong Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University; Ins…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Apoptosis, DNA Damage, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Patients with primary refractory or relapsed acute myeloid leukemia (AML) typically face a poor prognosis. Current chemotherapy regimens do not always achieve complete remission (CR) before transplantation, while facing the dilemma of high organ toxicity and no chance of transplantation in some patients. A combination of cladribine, cytarabine, and venetoclax (CAV) represents a novel salvage regimen. In this study, cladribine, cytarabine, and venetoclax alone or in combination significantly inhibited the proliferation of leukemia cell lines and primary cells in a dose-dependent manner, with the triple CAV combination exerting a far stronger inhibitory effect than any single agent or dual-drug combination (p < 0.01) and showing synergistic interactions (combination index
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University; Institute of Blood and Marrow Transplantation, Collaborative Innovation C…
- Jiangsu Province Engineering Research Center of Development and Translation of Key Technologies for Chronic Disease Prevention and Control, Suzhou Vocational Health College; liusongbai@126.com.
Zitieren
APA
Liu, F. T., Huang, Y. H., Ge, S. S., Wan, C. L., Wang, M., Zhang, Z. Z., Li, Y. Y., Liu, H. H., Pang, H. F., Lyu, X. Y., Li, Z., Dai, H. P., Liu, S. B., & Xue, S. L. (2026). The Regimen of Cladribine, Cytarabine, and Venetoclax (CAV) Induces Apoptosis in Acute Myeloid Leukemia Cells by Enhancing DNA Damage. Journal of Visualized Experiments. https://doi.org/10.3791/69797
Vancouver
Liu FT, Huang YH, Ge SS, Wan CL, Wang M, Zhang ZZ, et al. The Regimen of Cladribine, Cytarabine, and Venetoclax (CAV) Induces Apoptosis in Acute Myeloid Leukemia Cells by Enhancing DNA Damage. Journal of Visualized Experiments. 2026. doi:10.3791/69797
BibTeX
@article{Liu2026,
author = {Liu, Fang-Tong and Huang, Yuan-Hong and Ge, Shuai-Shuai and Wan, Chao-Ling and Wang, Miao and Zhang, Zhi-Zhi and Li, Yan-Yan and Liu, Hai-Hui and Pang, Hong-Feng and Lyu, Xiao-Yu and Li, Zheng and Dai, Hai-Ping and Liu, Song-Bai and Xue, Sheng-Li},
title = {The Regimen of Cladribine, Cytarabine, and Venetoclax (CAV) Induces Apoptosis in Acute Myeloid Leukemia Cells by Enhancing DNA Damage},
journal = {Journal of Visualized Experiments},
year = {2026},
doi = {10.3791/69797}
}
EUVIMED